Euclidean Capital LLC

Overview

• HeadquartersWilmington, United States²
• Legal formLimited Liability Company²
• LEI54930088UJIT3V1XWZ07²
• StatusActive²
• LEI statusIssued and current²
• Registered addressC/O CORPORATION SERVICE COMPANY, 19808 Wilmington, United States²
• Registered withDivision of Corporations, Department of State, 4728670²

See how the biggest companies compare on our leaderboards

Corporate structure

Euclidean Capital LLC sits at the top of its group. 2 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (1 companies). Each entity in the chart links to its source.

Timeline

1. Sep 9, 2009Founded Euclidean Capital LLC is founded²

Filings

25 filings to the SEC since October 2021: 25 other. The latest 20:

1. Aug 31, 2026N-PX EDGAR
2. Aug 14, 202613F-HR EDGAR
3. May 15, 202613F-HR EDGAR
4. Feb 17, 202613F-HR EDGAR
5. Nov 14, 202513F-HR EDGAR
6. Sep 2, 2025N-PX EDGAR
7. Aug 14, 202513F-HR EDGAR
8. May 15, 202513F-HR EDGAR
9. Feb 14, 202513F-HR EDGAR
10. Nov 14, 202413F-HR EDGAR
11. Aug 30, 2024N-PX EDGAR
12. Aug 14, 202413F-HR EDGAR
13. May 15, 202413F-HR EDGAR
14. Feb 14, 202413F-HR EDGAR
15. Dec 1, 202313F-HR/A EDGAR
16. Nov 14, 202313F-HR EDGAR
17. Aug 14, 202313F-HR EDGAR
18. May 15, 202313F-HR EDGAR
19. Feb 14, 202313F-HR EDGAR
20. Nov 14, 202213F-HR EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

Euclidean Capital LLC has told the SEC it owns more than 5% of 1 company, latest first (Schedules 13D and 13G).

• PMV Pharmaceuticals, Inc.SCHEDULE 13G/A Oct 18, 2021 to May 15, 2026³